Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 2/20 | 0.47 |
| ▸ | MAX | P61244 | 2/20 | 0.47 |
| ▸ | MERTK | Q12866 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | TXNRD1 | Q16881 | 3/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15507763 | 1.00 | MYC (0.47) | MYCMAXMERTKAPPTXNRD1 | |
| SCHEMBL31528961 | 0.90 | MYC (0.45) | MYCMAXMERTKAPPTXNRD1 | |
| SCHEMBL4652551 | 0.85 | MYC (0.44) | MYCMAXMERTKTXNRD1ALDH1A1 | |
| SCHEMBL31326382 | 0.83 | MYC (0.44) | MYCMAXMERTKTXNRD1HTT | |
| SCHEMBL4651273 | 0.83 | MYC (0.53) | MYCMAXMERTKAPPTXNRD1 | |
| SCHEMBL30068176 | 0.83 | MYC (0.53) | MYCMAXMERTKAPPTXNRD1 | |
| SCHEMBL14348284 | 0.82 | MERTK (0.47) | MYCMAXMERTKAPPTXNRD1 | |
| SCHEMBL4653656 | 0.80 | MYC (0.57) | MYCMAXMERTKAPPALDH1A1 | |
| SCHEMBL4651445 | 0.80 | MYC (0.57) | MYCMAXMERTKAPPALDH1A1 | |
| SCHEMBL21515029 | 0.80 | LMNA (0.47) | MYCMAXTXNRD1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4605392-A1 | METHODS FOR TREATING CANCER | Antares Therapeutics, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| WO-2024086809-A1 | METHODS FOR TREATING CANCER | SCORPION THERAPEUTICS, INC. (US) | 2024-04-25 | — | — | WO | disclosed |